Dyadic International (DYAI) to Release Quarterly Earnings on Wednesday

Dyadic International (NASDAQ:DYAI) is expected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $1.60 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Dyadic International Price Performance

NASDAQ:DYAI opened at $1.41 on Monday. The company has a 50-day moving average of $1.49 and a 200-day moving average of $1.42. The company has a market capitalization of $41.72 million, a price-to-earnings ratio of -6.13 and a beta of 0.95. Dyadic International has a 52 week low of $0.93 and a 52 week high of $2.67. The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15.

Institutional Investors Weigh In On Dyadic International

A hedge fund recently raised its stake in Dyadic International stock. Bank of America Corp DE raised its stake in Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,132 shares of the biotechnology company’s stock after acquiring an additional 26,965 shares during the quarter. Bank of America Corp DE owned about 0.09% of Dyadic International worth $47,000 as of its most recent filing with the Securities and Exchange Commission. 27.95% of the stock is currently owned by hedge funds and other institutional investors.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.